Literature DB >> 16750193

Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.

Gordon Nareyeck1, Michael Zeschnigk, Gabriele Prescher, Dietmar R Lohmann, Gerasimos Anastassiou.   

Abstract

Uveal melanoma (UM) is the most common intraocular malignancy. Approximately 50% of UM patients die of metastases, which mainly arise from primary tumors with loss of an entire chromosome 3 (monosomy 3). To identify cell lines with monosomy 3 that may serve as a model system for UM with high metastatic potential, we determined the chromosome 3 status of previously established and frequently used UM cell lines by microsatellite analysis (Mel202, Mel285, Mel290, 92-1, OMM-1, OCM-1, OCM-3, OCM-8) and cytogenetic analysis (Mel202, Mel285, OCM-8). We found that none of these cell lines has monosomy 3. Therefore we established and characterized two novel cell lines, UPMM-1 and UPMM-2 that are both developed from primary uveal melanoma tissue samples with monosomy 3. The cell line UPMM-1 has retained the chromosome 3 status of the primary tumor. In UPMM-2 chromosome 3 has undergone duplication (isodisomy) and is present on the background of a hypotetraploid karyotype. Our data suggest that, UPMM-1 may serve as a model system to study the mechanisms underlying the metastatic potential of uveal melanomas with monosomy 3.

Entities:  

Mesh:

Year:  2006        PMID: 16750193     DOI: 10.1016/j.exer.2006.04.004

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  9 in total

1.  Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.

Authors:  Joseph C Manarang; Deborah C Otteson; Alison M McDermott
Journal:  Curr Eye Res       Date:  2017-09-14       Impact factor: 2.424

Review 2.  Culturing Uveal Melanoma Cells.

Authors:  Martina Angi; Mieke Versluis; Helen Kalirai
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

Review 3.  Authenticating cell lines in ophthalmic research laboratories.

Authors:  Robert Folberg; Shrihari S Kadkol; Shahar Frenkel; Klara Valyi-Nagy; Martine J Jager; Jacob Pe'er; Andrew J Maniotis
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

4.  Characterization of three cell lines derived from fine needle biopsy of choroidal melanoma with metastatic outcome.

Authors:  Barry L Burgess; Nagesh P Rao; Ascia Eskin; Stanley F Nelson; Tara A McCannel
Journal:  Mol Vis       Date:  2011-02-25       Impact factor: 2.367

Review 5.  Hindsight: Review of Preclinical Disease Models for the Development of New Treatments for Uveal Melanoma.

Authors:  Caoimhe Goldrick; Letizia Palanga; Bobby Tang; Grace Mealy; John Crown; Noel Horgan; Susan Kennedy; Naomi Walsh
Journal:  J Cancer       Date:  2021-06-04       Impact factor: 4.207

6.  Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth.

Authors:  Mariam El Filali; Irene Homminga; Willem Maat; Pieter A van der Velden; Martine J Jager
Journal:  Mol Vis       Date:  2008-09-24       Impact factor: 2.367

7.  p63 is required beside p53 for PERP-mediated apoptosis in uveal melanoma.

Authors:  Raheela Awais; David G Spiller; Michael R H White; Luminita Paraoan
Journal:  Br J Cancer       Date:  2016-09-01       Impact factor: 7.640

8.  Targeted silencing of the ADP-ribosyltransferase 3 gene inhibits the migration ability of melanoma cells.

Authors:  Jie He; Yongyun Li; Ying Wang; He Zhang; Shengfang Ge; Xianqun Fan
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

9.  Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression.

Authors:  Catarina Salgado; Celine Roelse; Rogier Nell; Nelleke Gruis; Remco van Doorn; Pieter van der Velden
Journal:  PLoS One       Date:  2020-04-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.